Author

S. Eckhardt

Observed names: S ECKHARDT, S Eckhardt

Institution: National Institute of Oncology

Observed institutions: Semmelweis University, Genentech, National Institute of Oncology, University of Colorado Denver

OpenAlex ID: A5113069938

Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicenter randomized trials and summary of other studies

1995 · H. Ludwig, A.M. Cohen, et al. · Annals of Oncology · 89

A phase I safety and pharmacokinetic study of apomab, a human DR5 agonist antibody, in patients with advanced cancer

2007 · D. Camidge, R. S. Herbst, et al. · Journal of Clinical Oncology · 38

Pain Killing with Calcitonin in Patients with Malignant Tumours

2009 · J. Szántó, S. József, et al. · Oncology · 35

Second Malignancies after Treatment for Hodgkin's Disease

2001 · E. Várady, B. Deák, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 18

Anticancer Drug Research

1987 · K. Lapis, S. Eckhardt · 10

Renal Cell Carcinoma – Xenotransplantation into Immunosuppressed Mice

2009 · L. Kopper, E. Magyarosy, et al. · Oncology · 6

Forms and Results of Mitolactol Therapy

2009 · I. Hindy, J. Szántó, et al. · Oncology · 5

Molecular biology and differentiation of cancer cells (oncogenes, growth factors, receptors)

1987 · K. Lapis, S. Eckhardt · Akadémiai Kiadó eBooks · 5

Comparative data on the action mechanism of 1,6-dibromo-1,6-dideoxy-D-mannitol and 1,4-dimethanesulfonyloxy-n-butane.

1966 · L Institóris, S Eckhardt, et al. · PubMed · 4

Results Obtained with Combination Therapy of VM-26, Natulan and Prednisolone in Generalized Hodgkin’s Disease

2009 · S. Eckhardt, E. Döbrentey, et al. · Chemotherapy · 3

Carcinogenesis and tumour progression

1987 · K. Lapis, S. Eckhardt · Akadémiai Kiadó eBooks · 3

412 POSTER An open-label study to characterize the pharmacokinetic (pk) parameters of erlotinib in patients with advanced solid tumors with adequate or moderately imparied hepatic function

2006 · C. O'Bryant, S. Eckhardt, et al. · European Journal of Cancer Supplements · 1

Introduction and Survey

1987 · C. D. Sherman, K. C. Calman, et al. · Springer eBooks · 1

Multiple Myeloma

1987 · S. Monfardini, K. Brunner, et al. · Springer eBooks · 1

Cancer Research and Treatment Today: Results, Trends and Frontiers

1987 · K. Lapis, S. Eckhardt · 1

[Evaluation of serum alpha-1-fetoprotein studies in patients with testicular tumors receiving adjuvant and curative chemotherapy].

1983 · I Tóth, I Bodrogi, et al. · PubMed · 1

Biopharmacological investigation of 6,6'methylene-bis/2,2,4-trimethyl-1,2-dihydroquinoline (MTDQ) a radical binding antioxidant of secondary amine type.

1977 · V Bär, V Erdélyi, et al. · PubMed · 1

[Clinical aspects, treatment and care of patients with plasmacytoma (longitudinal studies based on treatment and care of 100 patients)].

1976 · L István, I Hindy, et al. · PubMed · 1

[Clinical studies on a cytostatic mannitol derivative (BCM)].

1956 · S ECKHARDT, F HARTAI, et al. · PubMed · 1

Announcement

2009 · Hagop Kantarjian, Jaffer A. Ajani, et al. · Oncology

PDF

156 A phase I dose-escalation study with oral LY317615 (L) in combination with capecitabine (C) in advanced cancer patients

2004 · S. Holden, C. Britten, et al. · European Journal of Cancer Supplements

Organization of cancer care in Hungary.

1989 · S Eckhardt · PubMed

Human Tumour Immunobiology

1987 · S. Monfardini, K. Brunner, et al. · Springer eBooks

Tumours of the Eye

1987 · C. D. Sherman, K. C. Calman, et al. · Springer eBooks

Natural History of Cancer

1987 · C. D. Sherman, K. C. Calman, et al. · Springer eBooks

Works count: 47

Citation count: 224

H-index: 6

I10-index: 5